By / August 3, 2022

Zimbabwe Issues First Authorization for Medical CBD Use

Zimbabwe now allows the sale of cannabidiol (CBD) drugs as an adjunct to treatments given to patients.

The Zimbabwe Medicines Control Authority has urged all licensed hemp and cannabis producers, manufacturers, importers, exporters, and retail pharmacists to apply for permission to sell these products.

To follow this story as it develops, head to the play store and grab our free cannabis news app.

The regulator asked interested people to provide product samples and allow its officials to inspect production sites. “Unlicensed cannabis sellers will be prosecuted for selling unapproved drugs,” he said in a letter dated July 18.

Zimbabwe Began Legalization Process in 2018

Zimbabwe began legalizing medical cannabis in 2018, driven by economic realities. Long the country’s main export, tobacco sales have plummeted worldwide, forcing farmers and lawmakers in Zimbabwe to rethink its approach to agriculture.

Following this, in 2019, Zimbabwe lifted its ban on growing cannabis, setting the stage for the cultivation of industrial hemp for export. In the same year, the country issued the first license for a medical cannabis company to begin cultivation.

At the time, the production and possession of cannabis, called mbanje, was punishable by up to 12 years in prison. However, recreational use was, and will remain illegal.

A Major Turning Point

Zimbabwe’s decision marked a turning point in the country’s policy, which had remained very conservative on the subject until then. MPs who campaigned for legalization were often mocked. But the debate around the legalization of medical cannabis emerged as the country sought new agricultural outlets, pushed by Canadian producers.

Zimbabwe Has Big Hopes for Cannabis

Zimbabwe is already one of the largest tobacco producers in Africa and exports most of its production to China. But industry leaders have encouraged the country’s tobacco growers “to plant cannabis so that a quarter of their income will come from this plant by 2025”.

Last year, Zimbabwe exported 30 tons of industrial hemp to Switzerland, its first foray into the European market.

In May, Zimbabwean President Emmerson Mnangagwa commissioned a €25 million medical cannabis farm and processing plant to be operated by Swiss Bioceuticals Limited in Zimbabwe’s Western Province.

(Featured image by Nataliya Vaitkevich via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published by Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.